| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |